CD19 Is a Useful B Cell Marker After Treatment With Rituximab: Comment on the Article by Jones et al
SourceArthritis and Rheumatism, 65, 4, (2013), pp. 1130-1131
Article / Letter to editor
Display more detailsDisplay less details
Laboratory of Medical Immunology
Arthritis and Rheumatism
Upload full text
Use your RU credentials (u/z-number and password) tolog in with SURFconextto upload a file for processing by the repository team.